Radiomics for the detection of diffusely impaired myocardial perfusion: A proof-of-concept study using 13N-ammonia positron emission tomography

J Nucl Cardiol. 2023 Aug;30(4):1474-1483. doi: 10.1007/s12350-022-03179-y. Epub 2023 Jan 5.

Abstract

Aim: The current proof-of-concept study investigates the value of radiomic features from normal 13N-ammonia positron emission tomography (PET) myocardial retention images to identify patients with reduced global myocardial flow reserve (MFR).

Methods: Data from 100 patients with normal retention 13N-ammonia PET scans were divided into two groups, according to global MFR (i.e., < 2 and ≥ 2), as derived from quantitative PET analysis. We extracted radiomic features from retention images at each of five different gray-level (GL) discretization (8, 16, 32, 64, and 128 bins). Outcome independent and dependent feature selection and subsequent univariate and multivariate analyses was performed to identify image features predicting reduced global MFR.

Results: A total of 475 radiomic features were extracted per patient. Outcome independent and dependent feature selection resulted in a remainder of 35 features. Discretization at 16 bins (GL16) yielded the highest number of significant predictors of reduced MFR and was chosen for the final analysis. GLRLM_GLNU was the most robust parameter and at a cut-off of 948 yielded an accuracy, sensitivity, specificity, negative and positive predictive value of 67%, 74%, 58%, 64%, and 69%, respectively, to detect diffusely impaired myocardial perfusion.

Conclusion: A single radiomic feature (GLRLM_GLNU) extracted from visually normal 13N-ammonia PET retention images independently predicts reduced global MFR with moderate accuracy. This concept could potentially be applied to other myocardial perfusion imaging modalities based purely on relative distribution patterns to allow for better detection of diffuse disease.

Keywords: Radiomic features; myocardial flow reserve; positron emission tomography.

MeSH terms

  • Ammonia
  • Coronary Artery Disease* / diagnostic imaging
  • Coronary Circulation
  • Humans
  • Myocardial Perfusion Imaging* / methods
  • Nitrogen Radioisotopes
  • Perfusion
  • Positron-Emission Tomography / methods
  • Radiopharmaceuticals

Substances

  • Ammonia
  • Nitrogen-13
  • Nitrogen Radioisotopes
  • Radiopharmaceuticals